Factors Contributing to Medication Noncompliance of Newly Diagnosed Smear-Positive Pulmonary Tuberculosis Patients in the District of Colombo,Sri Lanka

Abstract

Medication noncompliance hinders effective tuberculosis control. This descriptive study investigates the factors contributing to medication noncompliance among new patients with smear-positive pulmonary tuberculosis on treatment at government health institutions in Colombo, Sri Lanka. In a cohort of patients aged ≥15 years (n = 326), 23% were found to be noncompliers (n = 74) on follow-up. The median age of noncompliers (50 years) was significantly higher than the compliers (45 years). In multivariate logistic regression analysis, factors associated with noncompliance are as follows: being a male, living alone or with extended family, experiencing side effects to medication, perceiving nonsusceptibility to adverse effects of illness, and perceiving no benefit in regular treatment. The participants of a focus group discussion on service factors opined that the reception at treatment facilities and the interaction with certain categories of staff were poor. Noncompliance is related to a multiplicity of factors involving patients and healthcare services.

Keywords

medication newly diagnosed noncompliance pulmonary tuberculosis smear positive

Get full access to this article

View all access options for this article.

References

John G. , Alimuddin Z. Tuberculosis-an epidemic of injustice. J Rl Coll Physicians Lond. 1997;31:637-639.

Salomon N. , Perlman DC , Rubenstein A. , Mandelman D. , McKinley FW , Yancovitz SR Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program. Int J Tuberc Lung Dis. 1997;1:397-404.

Round Table . Tuberculosis control-is DOTS the health breakthrough of the 1990s? World Health Forum. 1997;18:225-247.

Mitchison DA How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998;2:10-15.

National Program for Tuberculosis Control and Chest Diseases. Administrative Report. Colombo, Sri Lanka: Ministry of Health; 2001.

Lwanga SK , Lemeshow S. Sample size determination in health studies. Geneva, Switzerland: World Health Organization; 1991 .

Liam CK , Lim KH , Wong M. , Tang B. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis. 1999;3:300-309.

Florie B. , Adriaanse H. In search of factors responsible for non-compliance among tuberculosis patients in Wardha district, India. Soc Sci Med. 1992 ;34:291-306.

Gerard RK , Joyce AM , Jack ES Utility of the health belief model in examining medication compliance among psychiatric patients. Soc Sci Med. 1987;25:1205-1211.

10.

Respiratory Diseases Control Programme. General manual for tuberculosis control. Welisara, Sri Lanka: RDCP; 1997.

11.

World Health Organization, International Union Against Tuberculosis and Lung Disease (IUATLD), Royal Netherlands Tuberculosis Association (KNCV). Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001;5:213-215.

12.

Herath Hmpb. A study on tuberculosis patients who defaulted treatment at chest clinic, Kurunegala [Dissertation]. Colombo, Sri Lanka: Postgraduate Institute of Medicine; 1993.

13.

Sooriyaarachchi Mbud. Pulmonary tuberculosis: treatment seeking behaviour and compliance to treatment among patients and practice in relation to diagnosis and treatment among physicians in the district of Gampaha [Master Thesis]. Colombo, Sri Lanka. Postgraduate Institute of Medicine; 2002.

14.

World Health Organization. TB advocacy, a practical guide. Geneva, Switzerland: World Health Organization; 1999.

15.

Sevim T. , Aksoy A. , Atac G. , et al. Treatment adherence of 717 patients with tuberculosis in a social security system hospital in Istanbul, Turkey. Int J TubercLung Dis. 2002;6:25-31.

16.

Senaratne WV , Fernando HC , Chandra L. Who is likely to default tuberculosis treatment? [Abstract]. 111th Annual Sessions of Sri Lanka Medical Association; March 26, 1998; Colombo, Sri Lanka.

17.

Comolet TM , Rakotomalata R. Factors determining compliance with tuberculosis treatment in an urban environment, Tamatare, Madagascar. Int J Tuberc and Lung Dis. 1998;2:891-897.

18.

Tekle B. , Mariam DH , Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis. 2002;6:573-579.

19.

Cuneo W. , Snider DE Enhancing patient compliance with tuberculosis therapy. Clin Chest Med. 1989;3:375-379.

20.

Morisky DE , Malotte CK , Choi P. , et al. A patient education program to improve adherence rates with anti-tuberculosis drug regimes. Health Educ Q. 1990;17:253-267.

21.

Sreinbauer, Cecilia , Maddalen, Matilde. Theories and models for health promotion and behaviour change at the individual level. Youth: Choices and Change. PAHO.2000:49-54.

22.

Janz NK , Becker MH The Health Belief Model: a decade later. Health Educ Q. 1984;11:1-47.

23.

Fozsik CJ Compliance with tuberculosis therapy. Med Clin North Am. 1993;77:1289-1300.

24.

Voelker R. Shoe leather therapy is gaining on TB. JAMA. 1996;275:743-744.

25.

Zwarenstein M. , Schoeman JH , Vundule C. , Lombard CJ , Tatley M. Randomized controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet. 1998;352:1340-1343.

26.

Janakan N. Epidemiological pattern of tuberculosis and selected aspects of case management in the district of Colombo, Sri Lanka [Master Thesis]. Colombo, Sri Lanka: Postgraduate Institute of Medicine ; 2005.